Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

HCV-I.E.T. shows signs of efficacy in HCV nonresponders

Aug. 9, 2006

Inflammatory bowel disease compound NV-52 continues phase I testing

Aug. 9, 2006

Indian approval for phase II study of crofelemer in acute infectious diarrhea

Aug. 9, 2006

FDA approves MoviPrep

Aug. 3, 2006

Novel agents for HCV and gastric emptying cited in recent patents

Aug. 2, 2006

European orphan drug designation for CT-1

Aug. 1, 2006

Solvay and Eisai sign codevelopment agreement for SA-001 in Japan

July 31, 2006

Japanese approval for Baraclude

July 27, 2006

Cubist evaluates strategic options for HepeX-B

July 27, 2006

Tolevamer effective in Clostridium difficile-associated diarrhea

July 27, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...